Samphire Neuroscience Raises $5M Seed Round for Novel Neurotech Wearable Targeting Menstrual Pain
Samphire Neuroscience has raised $5 million in seed funding to expand its Nettle brain device for menstrual symptoms, following strong market reception since its European launch earlier this year. The round was led by Nordic venture capital firm Inventure VC, with participation from US-based Fortify Ventures.
Read More from the Global Wellness News ™